Definitive Contract H9240519C0004

Award Date 11/29/18
Potential Completion Date 8/30/21
Potential Value $2M
Funding Federal Agency
US Special Operations Command
Contracting Federal Agency
Defense Contract Management Agency
Ultimate Awardee
Not listed
Set-Aside Type
Total Small Business
Federal Contract Vehicle
Extent Competed
Full and Open Competition after exclusion of sources
Major Defense Program
Not listed
Pricing Type
Cost Plus Fixed Fee
Place of Performance
San Diego, CA 92121, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
4
Legislative Mandate
Employment Eligibility Verification
National Interest Action
Not listed
Research Type
SBIR Program Phase II Action
Primary Consortia Member
Not listed
Similar Awards
This is a $2,146,157.51 Small Business Innovation Research (SBIR) Phase II contract awarded by the United States Special Operations Command (USSOCOM) to Rejuvenate Bio Inc., a for-profit small business. The contract is for research and prototype development services related to neuroenhancement and human performance optimization technologies intended to enhance the capabilities of special operations forces. The contract is a cost-plus-fixed-fee definitive contract with a performance period from...
This contract was awarded by the United States Special Operations Command (USSOCOM) to Rejuvenate Bio Inc., a for-profit small business, to conduct a feasibility study under the Small Business Innovation Research (SBIR) Phase I program. The contract, valued at $149,991.00, is for research related to the topic of "Improving Human Performance Through Neuroenhancement" and has a completion date of May 9, 2019. The contract was designated as a total small business set-aside and is a...
Rejuvenate Bio Inc., a for-profit small business organization, was awarded a $1,445,046.00 Small Business Innovation Research (SBIR) Phase II contract (SBIR SOCOM182-0002) by the United States Special Operations Command (USSOCOM) to conduct research and prototype development related to neuroenhancement and human performance optimization technologies for special operations forces. The contract, which is a definitive cost-plus-fixed-fee contract, was designated as a total small business...
Rejuvenate Bio Inc., a for-profit small business, was awarded a $2,220,133.00 cost-plus-fixed-fee contract by the United States Special Operations Command (USSOCOM) to conduct Small Business Technology Transfer (STTR) Phase II research and prototype development related to neuroenhancement and human performance optimization technologies. The award, which was designated as a total small business set-aside, supports Rejuvenate Bio's ongoing research initiatives aimed at enhancing the capabilities...
This federal contract award, identified as H9240522C0005, was issued by the United States Special Operations Command (USSOCOM) to Rejuvenate Bio Inc., a small business, for the SBIR Phase II topic 182-002 "Neuroenhancement". The cost-plus-fixed-fee contract has a ceiling value of $2,992,731.00 and a final completion date of December 16, 2024. The contract was set aside for small businesses and involves research and prototype development services related to neuroenhancement and human...
This is a Small Business Innovation Research (SBIR) Phase I contract awarded by the United States Special Operations Command (USSOCOM) to Rejuvenate Bio Inc., a for-profit small business, for a feasibility study on "Enhanced Canine Performance, Protection and Survivability". The contract has a firm fixed price of $99,886.50 and a period of performance from November 21, 2017 to May 21, 2018. As an SBIR Phase I award, this contract is focused on the initial research and development of...
This is a firm fixed-price purchase order contract awarded by the United States Special Operations Command (USSOCOM) to Apollo Neuroscience, Inc., a self-certified small disadvantaged, woman-owned small business. The $149,823.60 contract is for a Phase I Small Business Innovation Research (SBIR) feasibility study under Topic SOCOM182-002, "Improving Human Performance through Neuroenhancement". The study is to be performed in Pittsburgh, PA and was awarded on November 7, 2018 with a...
This is a Small Business STTR (Small Business Technology Transfer) Phase II contract awarded by the U.S. Special Operations Command (USSOCOM) to Health Via Modern Nutrition Inc. for the project "STTR PH II TOPIC 17C HUMAN PERFORMANCE OPTIMIZATION HVMN". The contract has a ceiling value of $5,895,137.85 and is a Cost Plus Fixed Fee Definitive Contract with an Ultimate Completion Date of September 29, 2023. The contract is focused on research and development related to human...
This contract was awarded by the United States Special Operations Command (USSOCOM) to Eyvr Foods LLC, a small disadvantaged business, for a feasibility study under the Small Business Innovation Research (SBIR) Phase I program. The study is focused on the topic "IMPROVING HUMAN PERFORMANCE THROUGH SLEEP RESTORATION" with a potential value of $149,029.02. The contract is a firm fixed-price purchase order with a completion date of February 18, 2020. The place of performance is Cape...
<p>This is a $1,587,776.00 Cost Plus Fixed Fee contract awarded by the U.S. Special Operations Command (USSOCOM) to Eyvr Foods LLC, a self-certified small disadvantaged business. The contract is for SBIR Phase II research and a prototype deliverable related to sleep restoration. It is a Definitive Contract with an ultimate completion date of September 1, 2023. The contract was awarded on March 1, 2021 and is set aside for small businesses.</p>

This federal contract was awarded by the United States Special Operations Command (USSOCOM) to Rejuvenate Bio Inc., a for-profit small business, for SBIR Phase II research and prototype development related to neuroenhancement and human performance optimization technologies. The $1,975,972.00 cost-plus-fixed-fee contract was designated as a total small business set-aside. Rejuvenate Bio Inc. has previously received other SBIR Phase I, II, and II plus prototype development awards from USSOCOM, ranging from approximately $1.4 million to $2.2 million, to conduct research in these areas aimed at enhancing special operations forces capabilities. This contract has a period of performance from November 29, 2018 to August 30, 2021.

Generated 3/21/24, 9:24 PM